Cargando…
Chasing quality remission in acute myeloid leukemia: intensity of induction and residual disease
Autor principal: | Ofran, Yishai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388263/ https://www.ncbi.nlm.nih.gov/pubmed/37525958 http://dx.doi.org/10.3324/haematol.2023.283541 |
Ejemplares similares
-
The “7+3” regimen in acute myeloid leukemia
por: Rowe, Jacob M.
Publicado: (2022) -
The first achievement of complete remission in childhood leukemia by treatment with the folic acid antagonist aminopterin
por: Izraeli, Shai
Publicado: (2022) -
t(15;17) in acute promyelocytc leukemia
por: Ling, Victoria Y., et al.
Publicado: (2023) -
TCF3::HLF acute lymphoblastic leukemia: still challenging to cure thirty years later
por: Tasian, Sarah K.
Publicado: (2023) -
The polymerase chain reaction, so simple, so clever: the discovery that made minimal residual disease come true
por: Cavé, Hélène
Publicado: (2022)